Renal Manifestations in Inflammatory Bowel Disease: A Cohort Study During the Biologic Era

被引:14
|
作者
Dincer, Mevlut Tamer [1 ]
Dincer, Zeynep Toker [2 ]
Bakkaloglu, Oguz Kagan [3 ]
Yalin, Serkan Feyyaz [4 ]
Trabulus, Sinan [1 ]
Celik, Aykut Ferhat [3 ]
Seyahi, Nurhan [1 ]
Altiparmak, Mehmet Riza [1 ]
机构
[1] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Nephrol, Istanbul, Turkey
[2] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Rheumatol, Istanbul, Turkey
[3] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Gastroenterol, Istanbul, Turkey
[4] Dr Lutfi Kirdar City Hosp, Dept Nephrol, Istanbul, Turkey
来源
MEDICAL SCIENCE MONITOR | 2022年 / 28卷
关键词
Statistical Analysis C; Colitis; Ulcerative; Crohn Disease; Inflammatory Bowel Diseases; Nephrolithiasis; RISK-FACTORS; INTERSTITIAL NEPHRITIS; CROHNS-DISEASE; GLOMERULONEPHRITIS; NEPHROLITHIASIS; COMPLICATIONS; UROLITHIASIS; INVOLVEMENT; AMYLOIDOSIS; PREVALENCE;
D O I
10.12659/MSM.936497
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Renal involvement can complicate the course of inflammatory bowel disease (IBD). In this study, we aimed to analyze the extent of renal manifestations in patients with IBD (Crohn disease or ulcerative colitis) during the biologic era. Material/Methods: Patients diagnosed with and followed up for IBD for a period covering 16 years were retrospectively analyzed. Patients who received IBD diagnosis with clinical, endoscopic, and histopathological findings and were older than 18 years were enrolled in the study. Demographic, clinical, laboratory, and treatment data were retrieved from the patients??? medical records. Results: Of the 1874 patients analyzed, the diagnosis was ulcerative colitis in 1055 patients and Crohn disease in the remaining 819. Renal manifestations were found in 105 patients (5.6%), 55 (6.7%) of whom were diagnosed with Crohn disease and 50 (4.7%) with ulcerative colitis. Renal calculi was the most common renal manifestation for both Crohn disease and ulcerative colitis. Renal manifestations were related to disease activity and surgical resection history in patients with Crohn disease, whereas no such relationship was found in patients with ulcerative colitis. Conclusions: Renal manifestations may be seen in up to 6% of patients with IBD, and patients with Crohn disease seems to have more risk than do patients with ulcerative colitis. Nephrolithiasis is the most common form of renal involvement in IBD and is closely associated with disease activity. This relationship between IBD and renal manifestations should be considered, especially when there are subtle renal symptoms.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] CMV Reactivation Is Rare in the Era of Biologic Therapies for Inflammatory Bowel Disease
    Hissong, Erika
    Yantiss, Rhonda
    MODERN PATHOLOGY, 2018, 31 : 269 - 269
  • [22] Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease
    Florholmen, Jon
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (01) : 43 - 52
  • [23] Oral Tacrolimus for the Treatment of Refractory Inflammatory Bowel Disease in the Biologic Era
    Thin, Lena W. Y.
    Murray, Kevin
    Lawrance, Ian C.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (07) : 1490 - 1498
  • [24] CMV Reactivation Is Rare in the Era of Biologic Therapies for Inflammatory Bowel Disease
    Hissong, Erika
    Yantiss, Rhonda
    LABORATORY INVESTIGATION, 2018, 98 : 269 - 269
  • [25] Role of hospitalization for inflammatory bowel disease in the post-biologic era
    Soriano, Celine R.
    Powell, Charleston R.
    Chiorean, Michael V.
    Simianu, Vlad V.
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (26) : 7632 - 7642
  • [26] Declining Rates of Surgery for Inflammatory Bowel Disease in the Era of Biologic Therapy
    Lowe, Sarina C.
    Sauk, Jenny S.
    Limketkai, Berkeley N.
    Kwaan, Mary R.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (01) : 211 - 219
  • [27] Declining Rates of Surgery for Inflammatory Bowel Disease in the Era of Biologic Therapy
    Sarina C. Lowe
    Jenny S. Sauk
    Berkeley N. Limketkai
    Mary R. Kwaan
    Journal of Gastrointestinal Surgery, 2021, 25 : 211 - 219
  • [28] Study of the rheumatological manifestations of inflammatory bowel disease
    Fernandez-Castro, M.
    Munoz, P.
    Silva, L.
    Godo, J.
    Abreu, L.
    Sanz, J.
    Andreu, J. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 215 - 215
  • [29] The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort
    Hiller, Aimee
    Biedermann, Luc
    Fournier, Nicolas
    Butter, Matthias
    Vavricka, Stephan R.
    Ciurea, Adrian
    Rogler, Gerhard
    Scharl, Michael
    Anderegg, Claudia
    Bauerfeind, Peter
    Beglinger, Christoph
    Begre, Stefan
    Belli, Dominique
    Bengoa, Jose M.
    Biedermann, Luc
    Bigler, Beat
    Binek, Janek
    Blattmann, Mirjam
    Boehm, Stephan
    Borovicka, Jan
    Braegger, Christian P.
    Brunner, Nora
    Buhr, Patrick
    Burnand, Bernard
    Burri, Emanuel
    Buyse, Sophie
    Cremer, Matthias
    Criblez, Dominique H.
    de Saussure, Philippe
    Degen, Lukas
    Delarive, Joakim
    Doerig, Christopher
    Dora, Barbara
    Dorta, Gian
    Egger, Mara
    Ehmann, Tobias
    El-Wafa, Ali
    Engelmann, Matthias
    Ezri, Jessica
    Felley, Christian
    Fliegner, Markus
    Fournier, Nicolas
    Fraga, Montserrat
    Frei, Pascal
    Frei, Remus
    Fried, Michael
    Froehlich, Florian
    Funk, Christian
    Furlano, Raoul Ivano
    Gallot-Lavallee, Suzanne
    PLOS ONE, 2019, 14 (04):
  • [30] MUSCULOSKELETAL MANIFESTATIONS IN A COHORT OF 234 INFLAMMATORY BOWEL DISEASE PATIENTS
    Fernandes, B. M.
    Bernardes, M.
    Goncalves, D. R.
    Magro, F.
    Costa, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 919 - 920